Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

Randomized, blinded, placebo-controlled, Phase 2 study of INBRX-109 in unresectable or metastatic conventional chondrosarcoma patients.

Disease Sites: Sarcoma

Phase: II

Investigator: Davis, Elizabeth

NCTID: NCT04950075

Protocol No: VICCSAR2165